Phase 3 Trial Data Supports Efficacy of Novel Treatment for ADHD in Adults
The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.
Stay updated with breaking news from Sustained Release. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Global Sustained Release Excipients Market Global Sustained Release Excipients Market Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Sustained Release Excipients Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global sustained release excipients market is expected to grow from $1.18 billion in 2022 to $1.29 billion in 2023 at a compound annual growth rate (CAGR) of 9.8%. The sustained release excipients market is expected to reach $1.80 billion in 2027
According to the report published by Allied Market Research, the global medical/diagnostic imaging market garnered $38.5 billion in 2020, and is expected to reach $68.8 billion by 2030, witnessing a CAGR of 5.8% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, si...
According to a market research study published by Zion Market Research, Global Pharmaceutical Solid Dosage Contract Manufacturing Market size & share...